PNC Financial Services Group’s Global Cord Blood Corporation CO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-32,920
Closed -$231K 4276
2019
Q1
$231K Hold
32,920
﹤0.01% 2061
2018
Q4
$212K Hold
32,920
﹤0.01% 2022
2018
Q3
$230K Buy
32,920
+10,000
+44% +$75.1K ﹤0.01% 2121
2018
Q2
$218K Buy
22,920
+10,000
+77% +$95.8K ﹤0.01% 2134
2018
Q1
$132K Hold
12,920
﹤0.01% 2415
2017
Q4
$129K Buy
+12,920
New +$141K ﹤0.01% 2441
2017
Q3
Sell
-10,000
Closed -$95K 4322
2017
Q2
$95K Hold
10,000
﹤0.01% 2555
2017
Q1
$67K Hold
10,000
﹤0.01% 2746
2016
Q4
$61K Buy
+10,000
New +$49.8K ﹤0.01% 2743
2015
Q1
Sell
-1,200
Closed -$6K 4813
2014
Q4
$6K Buy
+1,200
New +$5.7K ﹤0.01% 3526

Other funds holding CO

PNC Financial Services Group's CO Position: Q2 2019 in Review

PNC Financial Services Group sold out of Global Cord Blood Corporation (CO) in Q2 2019, closing a stake of 32,920 shares — an estimated $231K sold.

PNC Financial Services Group first reported a position in CO in Q4 2014 and held it in 10 quarters. The position peaked at $231K in Q1 2019. 40 funds tracked by Wall St. Rank hold CO as of Q2 2019.

  • PNC Financial Services Group reported no remaining Global Cord Blood Corporation position as of Q2 2019 after selling out during the quarter.
  • PNC Financial Services Group sold 32,920 Global Cord Blood Corporation shares in Q2 2019, an estimated $231K.
  • PNC Financial Services Group first reported a position in Global Cord Blood Corporation in Q4 2014 and held it in 10 quarters.
  • PNC Financial Services Group's Global Cord Blood Corporation position peaked at $231K in Q1 2019.
  • 40 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2019.

Based on PNC Financial Services Group's 13F filing for Q2 2019, filed 9 Aug 2019.